ALPS Medical Breakthroughs ETF
Health/Biotechnology
SBIO
1290 Broadway, Suite 1000,
Denver , CO, 80203
Denver , CO, 80203
Price
-
$ 33.82
0 %
+0.51
Dec 20, 2024
- Last Close
- Net Assets
-
$119M
Apr 26, 2024
- 52-Week High/Low
- $42.43 - $30.46
- Expense Ratio
- -
Link
Directors
Feb 13, 2024- Rick A. Pederson
- Edmund J. Burke
- Jeremy W. Deems
- Mary K. Anstine
Chief Compliance Officer
- Matthew Sutula
Company Name |
Holding |
| More | 1.88 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | 8.5% | -10.5% | -20.4% | -1.9% | -24.9% | 28.6% |
| Q2 | -5.5% | 16.1% | -17.7% | -2.7% | 32% | 0.6% |
| Q3 | - | -13.7% | 8.8% | -7% | -1.7% | -14% |
| Q4 | - | 25.8% | 0.8% | -7.2% | 24.6% | 33.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.8% | 11.6% | -3.5% | -8.3% | 2.7% | - | - | - | - | - | - | - |
| 2023 | 7.2% | -7% | -10.2% | 10.3% | 5.5% | -0.2% | 1.4% | -7.1% | -8.5% | -9.8% | 7.3% | 25.1% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.2% | 8.4% | -28.1% | -17.5% | 21.4% | 50% | -11.8% | 45.7% | -27.8% | 22.9% | 0% |